Investigation of the Properties of the Heavy Scintillating Fibers for Their Potential Use in Hadron Therapy Monitoring

Author(s):  
K. Rusiecka ◽  
J. Kasper ◽  
A. Magiera ◽  
A. Stahl ◽  
A. Wrońska
2016 ◽  
Vol 119 ◽  
pp. S270 ◽  
Author(s):  
F. Pennazio ◽  
M. Bisogni ◽  
N. Camarlinghi ◽  
P. Cerello ◽  
E. Fiorina ◽  
...  

2012 ◽  
Vol 102 ◽  
pp. S145-S146
Author(s):  
I. Torres-Espallardo ◽  
J. Gillam ◽  
P. Solevi ◽  
G. Llosa Lacer ◽  
V. Stankova ◽  
...  

Proceedings ◽  
2019 ◽  
Vol 42 (1) ◽  
pp. 71
Author(s):  
Jorge Otero ◽  
Ivan Felis ◽  
Miguel Ardid ◽  
Alicia Herrero ◽  
José A. Merchán

A full chain simulation of the acoustic hadron therapy monitoring for brain tumors is presented in this work. For the study, a proton beam of 100 MeV was considered. In the first stage, Geant4 was used to simulate the energy deposition and to study the behavior of the Bragg peak. The energy deposition in the medium produced local heating that can be considered instantaneous with respect to the hydrodynamic time scale producing a sound pressure wave. The resulting thermoacoustic signal was subsequently obtained by solving the thermoacoustic equation. The acoustic propagation was simulated by the Finite Element Method (FEM) in the brain and the skull, where a set of piezoelectric sensors were placed. Lastly, the final received signals in the sensors were processed in order to reconstruct the position of the thermal source and, thus, to determine the feasibility and accuracy of acoustic beam monitoring in hadron therapy.


Cells ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 3185
Author(s):  
Ilaria Saltarella ◽  
Aurelia Lamanuzzi ◽  
Benedetta Apollonio ◽  
Vanessa Desantis ◽  
Giulia Bartoli ◽  
...  

Multiple myeloma (MM) progression closely depends on the bidirectional crosstalk between tumor cells and the surrounding microenvironment, which leads to the creation of a tumor supportive niche. Extracellular vesicles (EVs) have emerged as key players in the pathological interplay between the malignant clone and near/distal bone marrow (BM) cells through their biologically active cargo. Here, we describe the role of EVs derived from MM and BM cells in reprogramming the tumor microenvironment and in fostering bone disease, angiogenesis, immunosuppression, drug resistance, and, ultimately, tumor progression. We also examine the emerging role of EVs as new therapeutic agents for the treatment of MM, and their potential use as clinical biomarkers for early diagnosis, disease classification, and therapy monitoring.


2006 ◽  
Vol 51 (9) ◽  
pp. 2143-2163 ◽  
Author(s):  
Paulo Crespo ◽  
Georgy Shakirin ◽  
Wolfgang Enghardt

2010 ◽  
Vol 57 (1) ◽  
pp. 144-150 ◽  
Author(s):  
Mirela Frandes ◽  
Andreas Zoglauer ◽  
Voichita Maxim ◽  
Rémy Prost

Sign in / Sign up

Export Citation Format

Share Document